David R. Turton

2.4k total citations
48 papers, 1.9k citations indexed

About

David R. Turton is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David R. Turton has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in David R. Turton's work include Medical Imaging Techniques and Applications (15 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Neuroscience and Neuropharmacology Research (11 papers). David R. Turton is often cited by papers focused on Medical Imaging Techniques and Applications (15 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Neuroscience and Neuropharmacology Research (11 papers). David R. Turton collaborates with scholars based in United Kingdom, Netherlands and Switzerland. David R. Turton's co-authors include Victor W. Pike, Adriaan A. Lammertsma, Terry Jones, Sajinder K. Luthra, Carl Smythe, David J. Brooks, Martin R. Gill, Jim A. Thomas, S. Osman and Keith Poole and has published in prestigious journals such as Angewandte Chemie International Edition, Circulation and NeuroImage.

In The Last Decade

David R. Turton

48 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David R. Turton United Kingdom	24	825	536	433	297	214	48	1.9k
Hank F. Kung United States	33	1.3k 1.6×	841 1.6×	840 1.9×	257 0.9×	275 1.3×	113	3.3k
Jorge R. Barrio United States	30	1.0k 1.2×	1.1k 2.0×	207 0.5×	403 1.4×	146 0.7×	51	2.9k
Erik Årstad United Kingdom	25	876 1.1×	694 1.3×	295 0.7×	223 0.8×	329 1.5×	62	2.2k
Elaine M. Jagoda United States	29	1.2k 1.5×	794 1.5×	495 1.1×	456 1.5×	102 0.5×	102	2.4k
Françoise Hinnen France	26	718 0.9×	1.1k 2.0×	424 1.0×	225 0.8×	122 0.6×	66	2.2k
David R. Elmaleh United States	29	891 1.1×	558 1.0×	647 1.5×	123 0.4×	136 0.6×	120	2.7k
C. Prenant France	21	726 0.9×	538 1.0×	557 1.3×	139 0.5×	112 0.5×	67	1.8k
Hidekazu Kawashima Japan	26	591 0.7×	515 1.0×	262 0.6×	193 0.6×	88 0.4×	84	2.0k
Kazuhiro Shiba Japan	24	597 0.7×	572 1.1×	299 0.7×	363 1.2×	92 0.4×	153	1.7k
Bertrand Kühnast France	31	1.1k 1.3×	1.2k 2.2×	363 0.8×	576 1.9×	131 0.6×	99	3.1k

Countries citing papers authored by David R. Turton

Since Specialization

Citations

This map shows the geographic impact of David R. Turton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Turton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Turton more than expected).

Fields of papers citing papers by David R. Turton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Turton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Turton. The network helps show where David R. Turton may publish in the future.

Co-authorship network of co-authors of David R. Turton

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Turton. A scholar is included among the top collaborators of David R. Turton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Turton. David R. Turton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Pieve, Chiara Da, et al.. (2022). New Fully Automated Preparation of High Apparent Molar Activity 68Ga-FAPI-46 on a Trasis AiO Platform. Molecules. 27(3). 675–675. 18 indexed citations

2.

Ramu, Vadde, Martin R. Gill, Paul J. Jarman, et al.. (2015). A Cytostatic Ruthenium(II)–Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up‐regulating p27^KIP1. Chemistry - A European Journal. 21(25). 9185–9197. 46 indexed citations

3.

Baggaley, Elizabeth, Martin R. Gill, Nicola Green, et al.. (2014). Dinuclear Ruthenium(II) Complexes as Two‐Photon, Time‐Resolved Emission Microscopy Probes for Cellular DNA. Angewandte Chemie International Edition. 53(13). 3367–3371. 171 indexed citations

4.

Baggaley, Elizabeth, Martin R. Gill, Nicola Green, et al.. (2014). Dinuclear Ruthenium(II) Complexes as Two‐Photon, Time‐Resolved Emission Microscopy Probes for Cellular DNA. Angewandte Chemie. 126(13). 3435–3439. 24 indexed citations

5.

Turton, David R., et al.. (2014). Automated radiosynthesis of GMP quality [ 18 F]HX4 for PET imaging of hypoxia. Nuclear Medicine and Biology. 42(5). 494–498. 6 indexed citations

6.

Witney, Timothy H., Israt S. Alam, David R. Turton, et al.. (2012). Evaluation of Deuterated 18F- and 11C-Labeled Choline Analogs for Cancer Detection by Positron Emission Tomography. Clinical Cancer Research. 18(4). 1063–1072. 52 indexed citations

7.

Fortt, Robin, Matthias Glaser, David R. Turton, et al.. (2012). Radiosynthesis of the D2/3 agonist [3-11C]-(+)-PHNO using [11C]iodomethane. Applied Radiation and Isotopes. 73. 79–83. 4 indexed citations

8.

Egerton, Alice, Ella Hirani, Rabia Shabir Ahmad, et al.. (2009). Further evaluation of the carbon11‐labeled D_2/3agonist PET radiotracer PHNO: Reproducibility in tracer characteristics and characterization of extrastriatal binding. Synapse. 64(4). 301–312. 16 indexed citations

9.

Kenny, Laura, R. Charles Coombes, Inger Oulie, et al.. (2008). Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand ¹⁸F-AH111585 in Breast Cancer Patients. Journal of Nuclear Medicine. 49(6). 879–886. 237 indexed citations

10.

Asselin, Marie‐Claude, Alexander Hammers, David R. Turton, et al.. (2004). Initial kinetic analyses of the in vivo binding of the putative NMDA receptor ligand [C-11]CNS 5161 in humans. NeuroImage. 3 indexed citations

11.

Pike, Victor W., et al.. (1997). Automated chemoenzymatic synthesis of no-carrier-added [carbonyl-11C]propionyl l-carnitine for pharmacokinetic studies. Applied Radiation and Isotopes. 48(7). 917–924. 13 indexed citations

12.

McCarron, Julie A., David R. Turton, Victor W. Pike, & Keith Poole. (1996). Remotely-controlled production of the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635, via 11C-carboxylation of an immobilized Grignard reagent. Journal of Labelled Compounds and Radiopharmaceuticals. 38(10). 941–953. 102 indexed citations

13.

McCarron, Julie A., David R. Turton, Victor W. Pike, & Keith Poole. (1996). Remotely‐controlled production of the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635, via 11C-carboxylation of an immobilized Grignard reagent. Journal of Labelled Compounds and Radiopharmaceuticals. 38(10). 941–953. 3 indexed citations

14.

Lassen, Niels A., Peter Bartenstein, Adriaan A. Lammertsma, et al.. (1995). Benzodiazepine Receptor Quantification in vivo in Humans Using [¹¹C]Flumazenil and PET: Application of the Steady-State Principle. Journal of Cerebral Blood Flow & Metabolism. 15(1). 152–165. 176 indexed citations

15.

Luthra, Sajinder K., et al.. (1993). An automated system based on solid phase extraction and HPLC for the routine determination in plasma of unchanged carbon-11 L-deprenyl Carbon-11 diprenorphine; carbon-11 flumazenil; Carbon-11 raclopride and Carbon-11 Scherring 23390. Journal of Labelled Compounds and Radiopharmaceuticals. 32. 518–520. 27 indexed citations

16.

Pike, Victor W., Christer Halldin, C. Crouzel, et al.. (1993). Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites—current status. Nuclear Medicine and Biology. 20(4). 503–525. 107 indexed citations

17.

Lammertsma, Adriaan A., C. J. Bench, Gary Price, et al.. (1991). Measurement of Cerebral Monoamine Oxidase B Activity Using L-[¹¹C]Deprenyl and Dynamic Positron Emission Tomography. Journal of Cerebral Blood Flow & Metabolism. 11(4). 545–556. 53 indexed citations

18.

Price, Gary, S. K. Luthra, David R. Turton, et al.. (1990). Inhibition of brain monoamine oxidase-B by Ro19-6327 — in vivo measurerment using positron emission tomography. European Journal of Pharmacology. 183(2). 166–166. 4 indexed citations

19.

Brooks, David J., R. S. J. Frackowiak, Adriaan A. Lammertsma, et al.. (1986). A comparison between regional cerebral blood flow measurements obtained in human subjects using¹¹C-methylalbumin microspheres, the C¹⁵O₂steady-state method, and positron emission tomography. Acta Neurologica Scandinavica. 73(4). 415–422. 13 indexed citations

20.

Brady, F., et al.. (1984). Preparation of carbon-11 labelled albumin microspheres for human clinical use. The International Journal of Applied Radiation and Isotopes. 35(10). 983–984. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact